Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Research & Development: 2018-2024

Historic Research & Development for Eton Pharmaceuticals (ETON) over the last 7 years, with Dec 2024 value amounting to $3.3 million.

  • Eton Pharmaceuticals' Research & Development rose 120.20% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 1.14%. This contributed to the annual value of $3.3 million for FY2024, which is 2.02% down from last year.
  • As of FY2024, Eton Pharmaceuticals' Research & Development stood at $3.3 million, which was down 2.02% from $3.3 million recorded in FY2023.
  • Over the past 5 years, Eton Pharmaceuticals' Research & Development peaked at $14.1 million during FY2020, and registered a low of $3.3 million during FY2024.
  • In the last 3 years, Eton Pharmaceuticals' Research & Development had a median value of $3.3 million in 2023 and averaged $3.5 million.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Research & Development rose by 22.06% in 2020, and later tumbled by 55.79% in 2021.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Research & Development stood at $14.1 million in 2020, then plummeted by 55.79% to $6.2 million in 2021, then tumbled by 35.91% to $4.0 million in 2022, then dropped by 16.87% to $3.3 million in 2023, then dropped by 2.02% to $3.3 million in 2024.